Galena Pharma has its own pharmacovigilance system.

Consequently, we take responsibility for continuous assessment of the risk–benefit ratio of pharmaceuticals that are under development or already on the market. If necessary, we can take the appropriate measures to safeguard public health.

Our pharmacovigilance system allows us to act on behalf of customers as the holder of marketing authorisation for pharmaceuticals.

Rich text content

Ilpo Kantanen

Ilpo Kantanen

R&D Manager

ilpo.kantanen (at)